| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,208 |
2,888 |
$383K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,559 |
1,515 |
$184K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,213 |
1,146 |
$145K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
634 |
597 |
$76K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
372 |
355 |
$10K |
| 99050 |
|
3,496 |
3,209 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
631 |
347 |
$684.32 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,271 |
2,132 |
$633.77 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
14 |
14 |
$0.00 |
| 87807 |
|
19 |
19 |
$0.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
14 |
14 |
$0.00 |